Australia markets open in 3 hours 37 minutes

ORCL Sep 2022 70.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
28.580.00 (0.00%)
As of 11:09AM EDT. Market open.
Full screen
Previous close28.58
Open28.58
Bid29.75
Ask29.95
Strike70.00
Expiry date2022-09-16
Day's range28.58 - 28.58
Contract rangeN/A
Volume20
Open interest376
  • PR Newswire

    Pandemic-Driven Changes in Pharma Here to Stay as New Clinical Trial Models Take Hold

    COVID-19 physical distancing requirements forced change in how traditional clinical trials were conducted and a new Informa Pharma and Oracle study shows the industry is not looking back. Of the 251 people surveyed, 84% implemented alternative tactics to continue their existing clinical trials and/or start new trials during the pandemic. Of those respondents, 82% said these approaches had positively impacted their clinical trials overall. Looking to the future, 97% indicated their organization w

  • Bloomberg

    Harvard-Trained Designer Creates China Business Software Unicorn

    (Bloomberg) -- A Harvard University-educated designer has turned his content marketing platform into a unicorn, helped by investors betting on enterprise software as the next big opportunity in China’s tech industry.Most Read from BloombergCities' Answer to Sprawl? Go Wild.Hamburg Is at the Heart of Germany’s Growing Dilemma Over ChinaWhy Americans and Britons Are Rushing to Buy Idyllic Homes in ItalyOne of California’s Wealthiest Counties Could Run Out of Water Next SummerThe Top Money Maker at

  • PR Newswire

    Oracle Named a Leader in the Gartner Magic Quadrant for Cloud HCM Suites for 1,000+ Employee Enterprises

    Oracle today announced that it has been named a Leader for the sixth successive year in the 2021 Gartner® Magic Quadrant™ for Cloud HCM Suites for 1,000+ Employee Enterprises for Oracle Fusion Cloud Human Capital Management (HCM). The report evaluates vendors based on ability to execute and completeness of vision. Oracle was placed furthest to the right for completeness of vision for the fourth year in a row.